» Articles » PMID: 26692280

The Relationships Between Body Composition Characteristics and Cognitive Functioning in a Population-based Sample of Older British Men

Overview
Journal BMC Geriatr
Publisher Biomed Central
Specialty Geriatrics
Date 2015 Dec 23
PMID 26692280
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Current research has established obesity as one of the main modifiable risk factors for cognitive impairment. However, evidence on the relationships of total and regional body composition measures as well as sarcopenia with cognitive functioning in the older population remains inconsistent.

Methods: Data are based on 1,570 participants from the British Regional Heart Study (BRHS), a cohort of older British men from 24 British towns initiated in 1978-80, who were re-examined in 2010-12, aged 71-92 years. Cognitive functioning was assessed with the Test-Your-Memory cognitive screening tool. Body composition characteristics assessed using bioelectrical impedance analysis included total fat mass (FM), central FM, peripheral FM, and visceral fat level. Sarcopenia was defined using the European Working Group on Sarcopenia in Older People (EWGSOP) definition of severe sarcopenia and the Foundation for the National Institutes of Health (FNIH) sarcopenia project criteria.

Results: Among 1,570 men, 636 (41 %) were classified in the mild cognitive impairment (MCI) and 133 (8 %) in the severe cognitive impairment (SCI) groups. Age-adjusted multinomial logistic regressions showed that compared with participants in the normal cognitive ageing group, those with SCI were more likely to have waist circumference >102 cm, BMI >30 kg/m(2), to be in the upper quintile of total FM, central FM, peripheral FM and visceral fat level and to be sarcopenic. The relationships remained significant for total FM (RR = 2.16, 95 % CI 1.29-3.63), central FM (RR = 1.85, 95 % CI 1.09-3.14), peripheral FM (RR = 2.67, 95 % CI 1.59-4.48), visceral fat level (RR = 2.28, 95 % CI 1.32-3.94), BMI (RR = 2.25, 95 % CI 1.36-3.72) and waist circumference (RR = 1.63, 95 % CI 1.05-2.55) after adjustments for alcohol, smoking, social class, physical activity and history of cardiovascular diseases or diabetes. After further adjustments for interleukin-6 and insulin resistance, central FM, waist circumference and sarcopenia were no longer significantly associated with SCI.

Conclusions: Increased levels of peripheral FM, visceral fat level, and BMI are associated with SCI among older people. Distinct pathophysiological mechanisms link regional adipose tissue deposition and cognitive functioning.

Citing Articles

Associations of dynapenic abdominal obesity and its components with cognitive impairment among hemodialysis patients.

Zhou C, Peng J, Qian Z, Zhan L, Yuan J, Zha Y BMC Geriatr. 2025; 25(1):107.

PMID: 39962377 PMC: 11834324. DOI: 10.1186/s12877-024-05580-3.


Association of changes in predicted body composition with subsequent risk of dementia.

Kim S, Choi S, Lee G, Oh Y, Son J, Ko A Ann Clin Transl Neurol. 2024; 11(8):1952-1963.

PMID: 39010668 PMC: 11330214. DOI: 10.1002/acn3.52096.


Meta-analysis on the interrelationship between sarcopenia and mild cognitive impairment, Alzheimer's disease and other forms of dementia.

Amini N, Ibn Hach M, Lapauw L, Dupont J, Vercauteren L, Verschueren S J Cachexia Sarcopenia Muscle. 2024; 15(4):1240-1253.

PMID: 38715252 PMC: 11294028. DOI: 10.1002/jcsm.13485.


Association Between Mid-arm Muscle Circumference and Cognitive Function: A Longitudinal Study of Chinese Adults.

Spangler H, Lynch D, Howard A, Tien H, Du S, Zhang B J Geriatr Psychiatry Neurol. 2023; 37(4):272-281.

PMID: 37993115 PMC: 11089828. DOI: 10.1177/08919887231218087.


Clinical-grade human umbilical cord-derived mesenchymal stem cells improved skeletal muscle dysfunction in age-associated sarcopenia mice.

Wang C, Zhao B, Zhai J, Wang A, Cao N, Liao T Cell Death Dis. 2023; 14(5):321.

PMID: 37173309 PMC: 10182022. DOI: 10.1038/s41419-023-05843-8.


References
1.
Ferrara C, Goldberg A . Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance. Diabetes Care. 2001; 24(2):245-9. DOI: 10.2337/diacare.24.2.245. View

2.
Dam T, Peters K, Fragala M, Cawthon P, Harris T, McLean R . An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci. 2014; 69(5):584-90. PMC: 3991139. DOI: 10.1093/gerona/glu013. View

3.
Gustafson D, Backman K, Waern M, Ostling S, Guo X, Zandi P . Adiposity indicators and dementia over 32 years in Sweden. Neurology. 2009; 73(19):1559-66. PMC: 2777073. DOI: 10.1212/WNL.0b013e3181c0d4b6. View

4.
Anstey K, Cherbuin N, Budge M, Young J . Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev. 2011; 12(5):e426-37. DOI: 10.1111/j.1467-789X.2010.00825.x. View

5.
Bolanowski M, NILSSON B . Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis. Med Sci Monit. 2001; 7(5):1029-33. View